230 related articles for article (PubMed ID: 2127341)
1. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.
Burns FR; Paterson CA; Gray RD; Wells JT
Antimicrob Agents Chemother; 1990 Nov; 34(11):2065-9. PubMed ID: 2127341
[TBL] [Abstract][Full Text] [Related]
2. The effect of 2-mercaptoacetyl-L-phenylalanyl-L-leucine, a specific inhibitor of Pseudomonas aeruginosa elastase, on experimental Pseudomonas keratitis in rabbit eyes.
Spierer A; Kessler E
Curr Eye Res; 1984 Apr; 3(4):645-50. PubMed ID: 6562000
[TBL] [Abstract][Full Text] [Related]
3. The effect of a synthetic metalloproteinase inhibitor on corneal ulceration in alkali burns and pseudomonas keratitis.
Burns FR; Gray RD; Wells JT; Paterson CA
Matrix Suppl; 1992; 1():317-8. PubMed ID: 1480049
[No Abstract] [Full Text] [Related]
4. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by phosphoramidon of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes.
Kessler E; Spierer A
Curr Eye Res; 1984 Aug; 3(8):1075-8. PubMed ID: 6435958
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes.
Kessler E; Spierer A; Blumberg S
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1093-7. PubMed ID: 6409834
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
[TBL] [Abstract][Full Text] [Related]
8. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
O'Callaghan RJ; Engel LS; Hobden JA; Callegan MC; Green LC; Hill JM
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
Silbiger J; Stern GA
Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
[TBL] [Abstract][Full Text] [Related]
11. The Role of Elastase in Corneal Epithelial Barrier Dysfunction Caused by Pseudomonas aeruginosa Exoproteins.
Li Y; Wang Y; Li C; Zhao D; Hu Q; Zhou M; Du M; Li J; Wan P
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):7. PubMed ID: 34232259
[TBL] [Abstract][Full Text] [Related]
12. The role of Pseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis.
Ijiri Y; Yamamoto T; Kamata R; Aoki H; Matsumoto K; Okamura R; Kambara T
Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):521-8. PubMed ID: 8224956
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model.
Wei C; Zhu M; Petroll WM; Robertson DM
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5890-9. PubMed ID: 25125601
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
Li SA; Liu J; Xiang Y; Wang YJ; Lee WH; Zhang Y
Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
[TBL] [Abstract][Full Text] [Related]
15. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
[TBL] [Abstract][Full Text] [Related]
16. Late-onset Pseudomonas keratitis after radial keratotomy and subsequent laser in situ keratomileusis: case report and literature review.
Levy J; Hirsh A; Klemperer I; Lifshitz T
Can J Ophthalmol; 2005 Apr; 40(2):211-3. PubMed ID: 16049542
[No Abstract] [Full Text] [Related]
17. Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model.
Frucht-Pery J; Golan G; Hemo I; Zauberman H; Shapiro M
Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):532-4. PubMed ID: 8537030
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibitors of Pseudomonas aeruginosa elastase as potential drugs for the treatment of Pseudomonas keratitis.
Kessler E; Blumberg S
Antibiot Chemother (1971); 1987; 39():102-12. PubMed ID: 3118777
[No Abstract] [Full Text] [Related]
20. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor.
Tang A; Caballero AR; Marquart ME; Bierdeman MA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5993-6002. PubMed ID: 30572344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
